The Role of T-Cadherin (CDH13) in Treatment Options with Garcinol in Melanoma.
CDH13
T-cadherin
garcinol
malignant melanoma
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
12 May 2024
12 May 2024
Historique:
received:
18
04
2024
revised:
07
05
2024
accepted:
10
05
2024
medline:
25
5
2024
pubmed:
25
5
2024
entrez:
25
5
2024
Statut:
epublish
Résumé
Targeted therapies with chemotherapeutic agents and immunotherapy with checkpoint inhibitors are among the systemic therapies recommended in the guidelines for clinicians to treat melanoma. Although there have been constant improvements in the treatment of melanoma, resistance to the established therapies continues to occur. Therefore, the purpose of this study was to explore the function of garcinol with regards to specific cancer properties such as proliferation and apoptosis. Garcinol, a natural compound isolated from the plant also known as mangosteen (
Identifiants
pubmed: 38791932
pii: cancers16101853
doi: 10.3390/cancers16101853
pii:
doi:
Types de publication
Journal Article
Langues
eng